Track the Seelos Therapeutics, INC. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Seelos Therapeutics, INC. has logged 9 reports. Market capitalisation: €58. The latest transaction was reported on 1 March 2024 (Attribution). Among the most active insiders: Golembiewski Michael Joseph. Every trade is openly available.
9
Insider Decl.
n/a
Thresholds
n/a
5 ops.
Buy Volume
n/a
n/a
Sell Volume
43Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
12,500 shares@ €0.8058100.0% of flowCommon StockSEC:0001136261-22-000155:0
9 of 9 declarations
About Seelos Therapeutics, INC.
Seelos Therapeutics, INC. is a biopharmaceutical company focused on developing treatments for neurological and psychiatric disorders. It is listed on NASDAQ under the symbol SEEL.